Dr Bipin Adhikari
Contact information
Podcast interview
Research groups
Bipin Adhikari
Research physician, Social Sciences, and Infectious Diseases
Dr Bipin Adhikari is a social scientist and infectious-disease researcher with the Mahidol-Oxford Tropical Medicine Research Unit (MORU). His work sits at the intersection of health systems, communities, and global health research, exploring how social realities shape responses to infectious diseases and antimicrobial resistance across South and Southeast Asia.
Originally from Nepal, Bipin joined MORU in 2015 and completed his DPhil at the University of Oxford in 2019, where his research focused on community engagement for malaria elimination in Laos. Since then, he has continued to examine the social, ethical, and policy dimensions of global health interventions, drawing on qualitative and interdisciplinary approaches.
Through close collaboration with clinicians, policymakers, and communities, Bipin’s research aims to make health interventions and programmes more responsive, inclusive, and grounded in local experience. He is particularly interested in translating research into practice — ensuring that community voices inform national and regional strategies for disease control and health equity.
He also contributes to training and mentoring early-career researchers across Asia, supporting the growth of regional social-science capacity in global health. His ongoing projects span malaria elimination, antimicrobial resistance, and community-centred approaches to public health research.
Recent publications
Impact of an electronic clinical decision support algorithm (eCDSA) on antibiotic prescribing in primary care in Cambodia: A cluster randomised controlled trial
Journal article
Wynberg E. et al, (2026), International Journal of Infectious Diseases, 164, 108382 - 108382
Acrobatics for Antibiotics: Exploring circus-based engagement on community practices surrounding antimicrobial resistance in Cambodia
Journal article
Wijntuin R. et al, (2026), Wellcome Open Research, 11, 104 - 104
Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial
Journal article
Degaga TS. et al, (2026), The Lancet Infectious Diseases
Reimagining primary health care: a historical and contemporary scoping review of community-based primary health care models and innovations.
Journal article
Acharya S. et al, (2026), Preventive medicine reports, 62
Circus arts shine a spotlight on antimicrobial resistance in Cambodia
Journal article
Moul V. et al, (2026), International Health